Management holds virtual 2023 R&D investor update and an ASH Data review on December 12 at 11 am. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GMAB:
- AbbVie, Genmab present new data for bispecific antibody epcoritamab
- Genmab, AbbVie announce new data from Phase 1/2 EPCORE NHL-1 trial
- New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
- Genmab just upgraded at UBS, here’s why
- Capital Increase in Genmab as a Result of Employee Warrant Exercise